Abstract
To investigate the correlation between the CHADS2 score and risk of contrast-induced nephropathy (CIN), we conducted a retrospective study in patients who underwent elective percutaneous coronary intervention (PCI) and compared its accuracy with previous scoring systems. A total of 539 patients who underwent elective PCI were enrolled. Based on their underlying diseases, such as hypertension, diabetes, and kidney disease, CHADS2 score, R2CHADS2 score, and Mehran's risk score were calculated for each patient. Incidence of CIN was defined as a rise in serum creatinine >0.5 mg/dL or >25% increase in baseline within 48 hours after PCI. All study participants were followed up until October 2014, or until the occurrence of major adverse cardiovascular events (MACEs). Overall, 55 cases (10.2%) of CIN and 90 cases (16.7%) of MACEs were identified after participants were followed up for 1.57 ± 1.46 years. The study cohort was divided into three groups according to CHADS2 scores: score 0, score 1-2, and score 3-6. In multivariate analysis, an increase of 1 point in the CHADS2 score was independently associated with a 37% increase in the risk of CIN (odds ratio, 1.37; 95% confidence interval, 1.00-1.87; p = 0.048) and a 49% increase in MA...Continue Reading
References
Nov 1, 1983·AJR. American Journal of Roentgenology·S T CochranD J Roe
Jun 13, 2001·JAMA : the Journal of the American Medical Association·B F GageM J Radford
Oct 13, 2004·Circulation·Brian F GagePalle Petersen
Apr 23, 2005·Radiology·Marc C HeinrichMichael Uder
Apr 12, 2006·Circulation·Martin TepelNorbert Lameire
Apr 14, 2006·Kidney International. Supplement·R Mehran, E Nikolsky
Sep 5, 2008·JAMA : the Journal of the American Medical Association·Somjot S BrarRaoul J Burchette
Dec 6, 2012·Circulation·Jonathan P PicciniUNKNOWN ROCKET AF Steering Committee and Investigators
Jan 3, 2013·International Journal of Cardiology·Tze-Fan ChaoShih-Ann Chen
Jun 1, 2013·Journal of the American College of Cardiology·Hitinder S GurmDavid Share
Jul 23, 2013·Journal of Hypertension·Shao-Sung HuangJaw-Wen Chen
Oct 1, 2013·Journal of the Formosan Medical Association = Taiwan Yi Zhi·Fu-Tien ChiangUNKNOWN ACS Full Spectrum Registry Investigators
Nov 28, 2013·Journal of the Formosan Medical Association = Taiwan Yi Zhi·Jiann-Shing JengUNKNOWN Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators
Jan 5, 2014·The American Journal of Medicine·Walid Saliba, Gad Rennert
Mar 29, 2014·BioMed Research International·Antonella CaiazzaDomenico Russo
Jun 5, 2014·BioMed Research International·Michele AndreucciAdis Tasanarong
Aug 15, 2014·Atherosclerosis·Po-Chao HsuSheng-Hsiung Sheu
Sep 11, 2014·The American Journal of Cardiology·Shao-Sung HuangShing-Jong Lin
Oct 12, 2014·Journal of Cardiovascular Medicine·Davide CapodannoCorrado Tamburino
Dec 20, 2014·TheScientificWorldJournal·Michele AndreucciAshour Michael
Citations
Nov 3, 2017·Angiology·Fernando AlfonsoFernando Rivero
Jul 7, 2017·Scientific Reports·Hui PangZhenkun Zong
Aug 22, 2018·Scientific Reports·Cheng-Hsueh WuShing-Jong Lin
Feb 12, 2020·BMC Nephrology·Wenjun YinXiaocong Zuo
Feb 27, 2020·Scientific Reports·Yi-Lin TsaiShing-Jong Lin
Oct 27, 2020·High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension·Alparslan KilicDeniz Elcik
Nov 28, 2020·Scientific Reports·Ruey-Hsing ChouShing-Jong Lin
Nov 18, 2020·BMC Cardiovascular Disorders·Zhubin LunYong Liu
Nov 27, 2019·Kidney Diseases·Onur Baydar, Alparslan Kilic